Carroll Financial Associates, Inc. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 141 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.

Quarter-by-quarter ownership
Carroll Financial Associates, Inc. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$3,000
-98.4%
252
-98.3%
0.00%
-100.0%
Q2 2021$191,000
+1173.3%
14,844
+1384.4%
0.01%
+175.0%
Q2 2014$15,000
+25.0%
1,0000.0%0.00%0.0%
Q1 2014$12,000
+9.1%
1,0000.0%0.00%0.0%
Q4 2013$11,0001,0000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders